Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? [electronic resource]
- Antimicrobial agents and chemotherapy Dec 2013
- 5836-42 p. digital
Publication Type: Journal Article
1098-6596
10.1128/AAC.01519-13 doi
Anidulafungin Antifungal Agents--therapeutic use Candida--drug effects Candidiasis--drug therapy Caspofungin Drug Resistance, Fungal Echinocandins--therapeutic use Europe Humans Lipopeptides--therapeutic use Micafungin Microbial Sensitivity Tests--standards North America Observer Variation South America Species Specificity